Stock data
Autolus Therapeutics plc (AUTL)
Autolus Therapeutics plc (AUTL) reported revenue of US$75.39M and net income of -US$287.53M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$75.39M | — | -US$270.54M | -US$287.53M | — |
| 2024 | US$10.12M | — | -US$241.43M | -US$220.66M | — |
| 2023 | US$1.70M | — | -US$179.70M | -US$208.38M | — |
| 2022 | — | — | -US$143.41M | -US$148.84M | — |
| 2021 | — | — | -US$141.05M | -US$142.10M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$45.69M | -US$39.11M | — |
| 2026-03-31 | US$26.22M | -US$71.60M | — |
| 2025-12-31 | US$24.29M | -US$90.33M | — |
| 2025-09-30 | US$21.19M | -US$79.12M | — |
| 2025-06-30 | US$20.92M | -US$47.92M | — |
| 2025-03-31 | US$8.98M | -US$70.16M | — |
| 2024-12-31 | US$0.03M | -US$27.61M | — |
| 2024-09-30 | US$0.00M | -US$82.09M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.